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Abstract
OBJECTIVES: To evaluate the performance and safety of an adjustable semi-rigid annuloplasty ring for mitral regurgitation (MR) in a
multicentre study.
METHODS: Between March 2010 and December 2011, 30 subjects underwent mitral valve (MV) repair using the Cardinal adjustable
annuloplasty ring. This device is a semi-rigid ring allowing postimplantation size adjustment, under beating-heart conditions, to opti-
mize leaﬂet coaptation under echocardiographic guidance. Coaptation length was determined before and after adjustment by transoe-
sophageal echocardiography.
RESULTS: The study enrolled 21 (70%) male and 9 (30%) female subjects with a mean age of 64 years. The approach was conventional
midline sternotomy or mini-invasive right thoracotomy. Leaﬂet resection was done in 17 subjects, and chordal repair was used in 13.
Concomitant procedures included coronary artery bypass grafting in 2 (7%) subjects, atrial ablation in 4 (13%) and tricuspid repair in
4 (13%). There was 1 (3%) early death unrelated to the study device. Intraoperative ring adjustment was performed in 24 of the 30 sub-
jects. Residual MR was detected prior to adjustment in 6 subjects (4 mild and 2 moderate MR). Following adjustment, 5 subjects had
no MR and 1 had trace MR. After adjustment, mean coaptation length improved from 7 ± 3 to 10 ± 3 mm (P < 0.0001). All patients who
completed 1-year follow-up had less-than-mild MR, with the exception of 1 patient with ring dehiscence (and resultant 2+ MR) and
1 functional MR patient who developed recurrent 2+ MR due to persistent leaﬂet tethering.
CONCLUSIONS: MV repair with the Cardinal adjustable annuloplasty ring is a reliable technique that enables the adjustment of the
ring diameter on a beating heart under echocardiographic control. Such technology allows the optimization of leaﬂet coaptation,
providing minimal residual MR and durable repair.
Keywords: Mitral valve • Annuloplasty • Repair • Echocardiography • Coaptation length • Image-guided surgery • Reconstruction
INTRODUCTION
The ultimate objective of mitral valve (MV) repair is to restore
the largest possible coaptation surface by acting at multiple
levels: annular, leaﬂet and subvalvular levels. MV annuloplasty is
routinely performed to increase coaptation and to reinforce the
annulus following leaﬂet and subvalvular repair [1]. Correct sizing
of the annuloplasty ring is a crucial step to restoring the appro-
priate annular-to-leaﬂet ratio [2]. Conventional annuloplasty ring
sizing is based on anatomical assessment of the leaﬂets under
cardioplegic arrest. This static approach could lead to inappro-
priate device selection since the mitral complex is a dynamic
entity. Inappropriate sizing has been associated with insufﬁcient
leaﬂet coaptation and recurrent mitral regurgitation (MR) [3–5]
or systolic anterior motion (SAM) of the anterior mitral leaﬂet
[6, 7]. To overcome this limitation, adjustable ring devices are
under investigation [8, 9]. The new-generation adjustable rings
enable echo-guided, off-pump, beating-heart modulation of the
valve annulus under physiological conditions to optimize mitral-
repair anatomy and haemodynamics at various stages following
the implant.
Here, we report the 1-year outcome from a single-arm, non-
blinded, non-randomized, multicentre, prospective clinical study
†Presented at the 26th Annual Meeting of the European Association for
Cardio-Thoracic Surgery, Barcelona, Spain, 27–31 October 2012.
© The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
A
D
U
LT
C
A
R
D
IA
C
European Journal of Cardio-Thoracic Surgery 44 (2013) 913–918 ORIGINAL ARTICLE
doi:10.1093/ejcts/ezt128 Advance Access publication 25 March 2013
with intrapatient comparisons designed to assess feasibility,
safety and efﬁcacy of the Cardinal adjustable ring (Valtech
Cardio, Or Yehuda, Israel) implantation during MV repair.
MATERIALS AND METHODS
Patients with indication for MR correction [10] were enrolled
between March 2010 and December 2011 in four centres in
Europe. To date, 24 patients have completed 1-year follow-up.
Patients with acute endocarditis, heavily calciﬁed leaﬂets or
annulus, previously implanted prosthesis, concomitant aortic or
pulmonary valve implant, or life expectancy <12 months were
excluded by protocol. The feasibility endpoint included the tech-
nical implantation success rate of the Cardinal ring deﬁned as
the ability to size the annulus, to place the sutures in the
annulus, to place the sutures in the ring, to lower the ring onto
valve and to tie the sutures, with no damage to adjacent tissue
from the ring or handle. The operator assigned a score from 1 to
3 for each step of the procedures (3 being operator-friendly and
1 unacceptable performance). The technical feasibility of postim-
plantation adjustment was deﬁned as the ability to modify the
size of the annuloplasty ring, when required, after weaning from
cardiopulmonary bypass (CPB). The efﬁcacy endpoint was
deﬁned as the ability of the Cardinal ring to reduce MR
post-CPB, at hospital discharge, and at 30-day postoperatively.
Additional data collected included the effect of ring annuloplasty
on left ventricular reverse remodelling and on mitral leaﬂet
length of coaptation. Serious adverse events were adjudicated by
an independent Clinical Event Committee.
The Cardinal adjustable annuloplasty system
The Cardinal adjustable annuloplasty system received the CE
mark in 2012 (Fig. 1): it is designed for beating-heart adjustment
of ring size after implantation and is applicable to both degen-
erative and functional MR patients. The implant is a semi-rigid
ring having a metal core enclosed in a polyester fabric covering,
and attached to an adjustment mechanism comprised of a spool
with an inner wire.
The ring is D-shaped with one ﬂexible segment corresponding
to the posterior leaﬂet and a shorter, more rigid, segment corre-
sponding to the anterior leaﬂet. The adjustment mechanism,
integrated within the mid-portion of the anterior segment ring,
enables size adjustment before and after implantation. Three
ring sizes are currently available—small, medium and large (cov-
ering sizes from 24 to 40 mm)—while at the time of the clinical
trial only 2 sizes (small and large) were available.
A remote-adjustment tool temporarily attached to the adjust-
ment mechanism enables ring adjustment to the desired size
from outside the heart. Adjustment of ring size is obtained by
rotating a dial on the handle. Adjustment is bidirectional (both
contraction and expansion of the ring is possible) and is com-
pletely reversible until the adjustment handle is removed. All
instruments are long-shafted so that they can be used in min-
imally invasive surgery.
A set of sizers (covering sizes from 24 to 40 mm) is used to
measure the MV. The sizers are also used as ring holders.
Implantation procedure
The Cardinal ring system is implanted on CPB, under cardiople-
gic arrest and direct view, with a conventional suturing tech-
nique. Following leaﬂet repair, ring sizers are used to assess the
intercommissural distance, the surface area and the height of the
anterior leaﬂet, as for conventional MV ring sizing. The corre-
sponding Cardinal adjustable annuloplasty ring is selected and
mounted on the holder. In patients with degenerative MR, a
slightly oversized annuloplasty ring may be chosen in order to
retain the option of ring expansion after implantation. In the
case of functional MR, undersizing is not required since it is
achievable by ring contraction following implantation.
Figure 1: The Cardinal adjustable annuloplasty ring system. (A) The Cardinal
ring has two portions, an anterior and a posterior one, identiﬁable by a green
marker. The anterior portion is rigid and non-compressible. The posterior
one is ﬂexible and adjustable. The adjustment tool is positioned in the mid of
the anterior portion. (B) An intraoperative view of a cardinal ring with the
remote adjusting tool connected to the ring prior to adjustment. (C) The ad-
justment tool allows remote ring size modiﬁcations by rotating the posterior
knob on the handle. A numeric indicator is used to monitor the amount of
size adjustment.
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Following completion of the implant, ring size can be adjusted
according to standard water testing of the MV. The left atrium is
then closed in the usual fashion, with the exception that the ad-
justment handle traverses the atriotomy suture line in order that
ﬁnal ring size adjustment can be performed after weaning from
CPB. Haemodynamic status should be stable at the time of ad-
justment, with near-physiological arterial pressure and optimal
loading conditions.
Adjustment is guided by transesophageal echocardiography
(TEE), focusing on residual MR, degree of leaﬂet coaptation and
the presence of transmitral gradients. If residual MR is present,
size reduction can be attempted. In the case of no residual MR,
the operator can still consider adjusting the ring size in order to
obtain a larger surface of coaptation. The length of coaptation is
assessed in left ventricular outﬂow tract (LVOT) view, scanning
the coaptation line in different segments. The length of coapta-
tion should ideally be 8 mm or more throughout the coaptation
line. In the case of SAM, the ring may be enlarged until normal
leaﬂet coaptation is obtained. In the case of functional mitral
stenosis, the ring may be re-expanded.
Following ﬁnal ring size adjustment, the adjustment handle is
removed. A ﬁnal TEE evaluation of MV function is performed.
The operation is then completed in standard fashion.
Echocardiography
Echocardiogram was conducted in a standardized fashion using
a prespeciﬁed protocol. Clinical follow-up and transthoracic
echocardiography (TTE) assessment of left ventricular volumes
and function and MR degree/grade were made at hospital dis-
charge, 30 days, 6 months and annually postindex procedure.
Independent monitoring visits were routinely performed.
Analysis of echocardiographic data was reviewed by an inde-
pendent core laboratory (Medstar Health, WA, USA).
Statistical analysis
Data were analysed with a per-protocol approach. Statistical ana-
lysis was performed using the JMP 5.1.1 software (SAS Institute,
Inc., Cary, NC, USA). Continuous variables are presented as
mean ± SD throughout the manuscript. Univariable comparisons
were performed using the paired t-test. The level of signiﬁcance
was set at P = 0.05.
RESULTS
A total of 30 (21 males and 9 females) patients were enrolled
(mean age of 64 ± 14 years, range 30–5 years). Comorbidities
included hypertension in 16 (53%) patients, arrhythmias in
10 (30%), dyslipidaemia in 8 (27%), diabetes in 3 (10%), coronary
artery disease in 3 (10%), chronic lung disease in 1 (3%) and
history of cerebrovascular accident in 1 (3%). Most of the patients
(22, 73%) were in New York Heart Association (NYHA) functional
Class I–II, and 8 were in NYHA functional Class III–IV (27%).
According to core-lab assessment, all patients but 2 (with
moderate MR) had severe MR at baseline. There were 3 (10%)
patients with Carpentier Type I MR, 26 (87%) with Type II and 1
(3%) with Type III. There were 4 patients with mild associated
aortic regurgitation, and 12 with mild or moderate tricuspid re-
gurgitation. Baseline echocardiographic parameters are reported
in Table 1. A full sternotomy was performed in 12 patients, while
minimally invasive right thoracotomy was done in the remaining
18.
MV leaﬂet resection was performed in 17 (57%) patients and
chordal replacement in 13 (43%), while in 3 (10%), isolated ring
implantation was performed. Associated cardiovascular proce-
dures included tricuspid repair in 4 patients, atrial ﬁbrillation ab-
lation in 4 and coronary bypass surgery in 2.
Ring implantation was attempted in all patients and was suc-
cessful in all but one. The unsuccessful implant was in a patient
with fragile annular structure and the surgeon decided to
proceed with MV replacement.
The scores for the technical feasibility endpoint were: 2.9 ± 0.2
for sizing, 2.9 ± 0.2 for placing sutures in the annulus, 2.9 ± 0.3
for placing sutures in the ring, 2.9 ± 0.2 for lowering the ring
onto annulus and 2.9 ± 0.4 for tying the sutures; a score of 1 was
given only once to tying the sutures due to difﬁculties related to
the fragility of annulus, in the patient who underwent MV re-
placement. Average annular sizing prior to implant was 35 ± 4
mm. A small ring was implanted in 16 (53%) patients and a large
ring in 14 (47%).
Ring adjustment was done in 24 (80%) patients. It was per-
formed under cardioplegic arrest, according to water testing, in
3 patients and post-CPB, under TEE guidance in 16, and both
on- and post-CPB in 5. Adjustment was technically successful in
all patients (Fig. 2).
Residual MR was detected prior to adjustment in 6 subjects
(4 mild and 2 moderate). Following adjustment, 5 subjects had
no MR and 1 had trace MR. Ring enlargement was used to
correct SAM in 1 patient and to reduce transmitral gradients in
another patient.
Table 1: Left ventricular volumes, ejection fraction and septolateral annular dimension at baseline and follow-up
Baseline 1 month 6 months 12 months
LVEF (%) 63 ± 8 57 ± 9 (0.06) 59 ± 6 (0.13) 59 ± 3 (0.02)
LVEDV (ml) 136 ± 41 104 ± 29 (0.0002) 100 ± 25 (0.0006) 94 ± 19 (<0.0001)
LVESV (ml) 56 ± 21 50 ± 17 (0.18) 45 ± 13 (0.03) 42 ± 10 (0.001)
Annular SL (mm) 36 ± 4 21 ± 7 (<0.0001) 18 ± 4 (<0.0001) 17 ± 2 (<0.0001)
All variables are reported as mean ± 1 SD: the P-value is reported in brackets according to the paired t-test comparison with baseline.
LVEF: left ventricular ejection fraction; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; SL: septolateral.
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In the 16 patients who underwent post-CPB ring reduction,
coaptation length after adjustment was signiﬁcantly greater than
before adjustment (10 ± 3 vs 7 ± 3 mm; P < 0.0001, Figs 3 and 4).
More importantly, after adjustment, no patient had a coaptation
length <7 mm, when compared with 7 of the 16 patients with a
coaptation length <7 mm before adjustment.
There was 1 hospital death (30-day mortality, 3%), due to is-
chaemic lesion of the right coronary artery in a patient undergo-
ing combined mitral and tricuspid repairs by a minimally
invasive approach. This event was not related to the Cardinal
ring implantation.
At discharge, average left ventricular ejection fraction was
56 ± 9% and slightly reduced when compared with baseline
(Table 1). At 12-month follow-up, all patients but 3 were in
NYHA Class I or II. Reverse remodelling of the left ventricle was
observed with signiﬁcant volume reductions over time (Table 1).
The annular septolateral dimension was signiﬁcantly reduced
at 1 month from the procedure when compared with baseline
(21 ± 7 vs 36 ± 4 mm, P < 0.0001), while the dimensions did not
change signiﬁcantly at 6 months (18 ± 4 mm, P = 0.4, compared
with 1 month) and 1 year.
One patient required reoperation at 6 months from the index
procedure due to ring dehiscence and 2+ MR (Type II MR
treated with the minimally invasive approach).
One patient who had functional MR developed recurrent 2+
MR at 1-year follow-up due to ongoing remodelling.
The core-lab assessment of MR degrees at various follow-up
times compared with baseline are reported in Fig. 5.
DISCUSSION
The study proved both the safety and the efﬁcacy of the
Cardinal adjustable annuloplasty ring. The ring allows postim-
plantation ﬁne-tuning of annular size, to optimize leaﬂet coapta-
tion under TEE guidance during normal physiological conditions.
Mitral annuloplasty is considered a cornerstone of MV repair,
minimizing future recurrent MR after repair [1, 11].
The creation of a large area of leaﬂet coaptation is the
primary goal of durable mitral repair surgery [4, 12, 13].
Kunzelman et al. [14] showed that ring annuloplasty reduces
leaﬂet stress and improves coaptation. Several factors inﬂuence
Figure 3: Coaptation length changes following Cardinal ring size tuning.
Individual coaptation lengths before and after ring adjustments. The two dots
depict mean ± SD.
Figure 4: LVOT view of coaptation length. Coaptation length (mm) before (A)
and after adjustment (B) in a patient undergoing off-pump ring adjustment
under TEE echo-guidance (LVOT view).
Figure 2: Ring size adjustment. Of 30 patients undergoing Cardinal ring im-
plantation, 6 required no adjustment and 24 had the ring size modiﬁed after
the implant: in 3 cases under direct view, in 16 cases off-pump, and in 5
cases both on- and off-pump. (A) The Cardinal ring on three-dimensional live
transesophageal echocardiography showing the saddle shape of the ring on
the beating heart.
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leaﬂet coaptation, including annular size and shape, and the
amount of mobile leaﬂet tissue.
Surgeons can directly manipulate the ﬁrst two factors by ring
annuloplasty. The size of the ring annuloplasty is usually chosen
according to the intraoperative sizing of the anterior leaﬂet.
However, we previously reported that suboptimal mitral repair
may require an immediate surgical revision in up to 11% of
patients undergoing intraoperative TEE evaluation [15]. Early
repair failure is often related to annuloplasty ring sizing issues.
Incorrect ring undersizing may induce residual MR due to insuf-
ﬁcient leaﬂet coaptation. Early identiﬁcation of limited coapta-
tion is associated with poor long-term results and high MR
recurrence rates [4, 11, 16]. On the contrary, SAM occurs in up to
15% of patients following complex MV repair [6, 17] due to ex-
cessive ring undersizing [18]. Rings with increased septolateral
distance have been designed to reduce the occurrence of SAM
[19], although their effect on MR reduction may be questioned.
The Cardinal annuloplasty ring is a semi-rigid device preserv-
ing the natural movements of the native annulus. The ring is
speciﬁcally designed to provide anisotropic compliance: the
anterior segment is less compliant (similar to the heart’s skeletal
structure near the trigones) and the posterior segment more
compliant. This design feature promotes posterior annular
plication and preferential reduction of the septolateral dimen-
sion and may make this ring ideal to treat both degenerative
and functional MR. The ring size obtained intraoperatively is
maintained over time, as demonstrated in our study showing
that the annular septolateral dimension at 1 month remains
stable at 1 year. At follow-up, reverse remodelling of the left
ventricle and stable MR reduction are observed in most of the
patients.
The main advantage of the Cardinal annuloplasty system is
that size adjustment can be achieved after weaning from CPB,
on the beating heart. If residual MR is observed or leaﬂet coap-
tation is not adequate, the septolateral distance can be reduced.
Conversely, if SAM or increased gradients are observed, septolat-
eral distance can be increased. In our experience, adjustment of
the ring size was performed in 80% of the cases: the ring size
was more commonly reduced to improve leaﬂet coaptation
(from 7 ± 3 to 10 ± 3 mm), while in 2 cases it was increased to
reverse SAM or transmitral gradients. In all patients undergoing
size reduction under TEE guidance, ﬁnal coaptation length was
>7 mm, when compared with 44% of patients with <7 mm coap-
tation length before size adjustment. The adjustment man-
oeuvres were safe and totally reversible with no device-related
complications during adjustments.
In the present feasibility study, the number of patients treated
with functional MR was too small to generate conclusions.
Although the ring is designed to target functional MR, a more
dedicated study is warranted to determine the feasibility and the
efﬁcacy in this setting.
The use of an adjustable ring may be particularly helpful in
functional MR, because the operator could aggressively under-
size to improve leaﬂet coaptation and to adjust the septal lateral
diameter, while avoiding the risk of generating gradients [20–22].
Moreover, in the case of a suboptimal result, the surgeon may
avoid a second CPB run.
Late adjustment option could be intriguing since recurrent MR
is known to occur months to years after MV repair in a signiﬁ-
cant proportion of patients with ongoing LV remodelling. Langer
et al. [9] recently reported the 6-month results of the MiCardia
DYANA annuloplasty system (MiCardia Corp., Irvine, CA, USA), a
nitinol-based dynamic complete ring, which allows late modiﬁ-
cation of the septolateral diameter by radiofrequency. As an al-
ternative, transcatheter valve-in-ring procedures may successfully
treat recurrent MR [23] after MV annuloplasty.
The Cardinal ring can be adjusted only intraoperatively, but
allows ﬁne-tuning of annuloplasty ring size with greater degrees
of adjustments when compared with the nitinol-based technol-
ogy. In addition, the shape and size modiﬁcation is bidirectional
and totally reversible until the adjustment handle is removed.
In 1 patient with preoperative Type I MR, ring dehiscence oc-
curred. This risk may be mitigated by the ring implantation tech-
nique: more sutures may be required since ring reshaping
determines higher loads on the annular structures. Further
studies are required in order to conﬁrm this hypothesis.
In conclusion, the current study shows that implantation of
the adjustable Cardinal ring is safe and effective. This study has
shown that size adjustment was used in 80% of the patients, with
a positive effect on the surface of leaﬂet coaptation. Adjustment
may be used to correct either the lack of coaptation with re-
sidual MR, or to prevent SAM in the case of ring undersizing.
The clinical use of the adjustable annuloplasty rings can improve
acute and long-term results of mitral-repair surgery.
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APPENDIX. CONFERENCE DISCUSSION
Dr G. Dellgren (Gothenburg, Sweden): Dr Maisano and colleagues from four
European centres have described in this manuscript the clinical use of an ad-
justable mitral valve ring called the Cardinal. As described by the authors, it is
a device that allows adjustment of the ring after testing with saline, prior to
and after coming off bypass but not after sternal wound closure. Innovative it
is, and inevitably a device that may be of use since all of us have experienced
patients with residual MR after mitral valve repair, although not very
commonly.
In my opinion, Dr Maisano and colleagues have shown in a limited popula-
tion that the device can be used with a good short-term outcome, although
the conclusions drawn have to be cautious because of the small population.
I have one comment and one question. When I read this study, I became
curious about what the inclusion criteria really were because it includes 30
patients, not many, although performed in four centres, with different surgical
procedures or approaches in patients with different forms of MR, and with a
need for readjustment of the ring in about 80% of the cases. In addition, as
you referenced yourself, perhaps 5 or 10% of patients required re-exploration
intraoperatively due to residual MR.
So please comment on why the device was not used only in functional
MR, for which I think it was originally designed, or how you were planning
on performing the inclusion of patients into this study?
Dr Maisano: Your comments will allow me to elaborate a little bit more on
the baseline concept of these devices. First of all, this device has not been
designed speciﬁcally for degenerative or for functional MR. I think it could be
applied in both conditions, because in different ways, both would beneﬁt
from an adjustable, dynamic device. In the case of functional MR, obviously
the challenge is to identify the ring reduction which is associated with a rea-
sonable improvement of coaptation while preventing mitral stenosis.
In the case of degenerative MR, the concept of using an adjustable device
is again to improve coaptation to attempt to improve durability, as well as to
have the opportunity of enlarging the ring in case a SAM happens, and,
therefore, to optimize coaptation under beating conditions.
The study has not been designed to properly demonstrate the need for
such an adjustment. This was just a study to demonstrate the feasibility and
the safety of using such devices. In the study, which included only 30 patients,
there was one ring dehiscence which happened at the beginning of the
study, and I think this is already one lesson we have learned: these rings
should be implanted with a very careful technique to provide better control
and stable ﬁxation in case of ischaemic mitral regurgitation.
Dr P. Tozzi (Lausanne, Switzerland): Two quick questions. The ﬁrst one is, is
the correction reversible? And the second one, did you measure the gradient
across the valve just to avoid any stenosis?
Dr Maisano: The adjustment is fully reversible until the adjustment cable is
left in place. Before that time you can both reduce and enlarge the ring as
many times as you want until you get the intended result. In terms of docu-
menting the gradients, unfortunately we did not include this in our database,
although obviously this was one of the targets of the study, to obtain
maximum coaptation while avoiding SAM or increase in gradients.
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